Joachim G.J.V. Aerts

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Julie R. Brahmer, Karen L. Reckamp, Paul Baas et al. · New England Journal of Medicine · 2015 · 8.4K citations · Full text

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

Harry J. de Koning, Carlijn M. van der Aalst, Pim A. de Jong et al. · New England Journal of Medicine · 2020 · 3.3K citations · Full text

Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer

Willemijn S.M.E. Theelen, Heike Peulen, Ferry Lalezari et al. · JAMA Oncology · 2019 · 935 citations · Full text

Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction

Jun Hou, Joachim G.J.V. Aerts, Bianca den Hamer et al. · PLoS ONE · 2010 · 757 citations · Full text

The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes

Floris Dammeijer, Mandy van Gulijk, Evalyn E.A.P. Mulder et al. · Cancer Cell · 2020 · 626 citations · Full text

Cancer Immunosurveillance, Immunology, Tumor Immunity +7